Trial intelligence / Profile preview

Regulating Rheumatoid Arthritis

NL-OMON52768Recruiting

Sponsor
University Medical Center Utrecht
Start
Mar 2023
Countries
1
01

Overview

Open-label trial in rheumatoid arthritis (RA) (2 cohorts), sponsored by University Medical Center Utrecht. Primary endpoints: Objective 1 endpoint, Objective 2 endpoint and 2 more. Started Mar 2023; status: recruiting.

02

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NL-OMON52768.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON52768.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call